While Process Improvement is described as an “imperative to survival,” the majority of Med-Tech companies surveyed are still “chasing defects.”
Yardley, PA (PRWEB) September 30, 2013
For decades, Medical Technology (Med-Tech) companies have embarked in Process Improvement initiatives to enhance product quality while reducing costs.
So why are most companies chasing defects instead of improving processes?
Answers to this complex question are provided in a new research study released today by Axendia, Inc. For this major research Axendia surveyed 239 Medical Technology Industry practitioners from 96 different companies across 22 countries.
“While Process Improvement is described by many Med-Tech Executives as an imperative to survival, the benefits of these initiatives have eluded most companies in this sector,” commented Daniel R. Matlis, President of Axendia. “The data clearly shows that the majority of Med-Tech companies are still Chasing Defects.”
Key findings, analysis and recommendations from this research are available in a series of four white papers and accompanying video briefings under the umbrella: “Is Med-Tech Improving Processes or Chasing Defects.”
Each white paper addresses one of the following themes:
-The Many Sides of Process Improvement
-The Commitment Gap
-So Many Systems, So Little Improvement
To request a copy of these white papers, please visit http://pages.camstar.com/2013-stop-chasing-defects.
For additional information or to schedule an interview or briefing with the study’s lead researchers, please contact Lisa George via email at lgeorge(at)axendia(dot)com or by phone at +1 (267) 392-2009.
Axendia surveyed 239 Medical Technology Industry practitioners from 96 different companies across 22 countries. Percentages reported are based on those that responded to each individual question in the online survey. The research was also guided by insight from Industry Executives.
This study was sponsored by Camstar Systems Inc. ( http://www.camstar.com ). The company supported this research to increase the understanding of processes improvement initiatives across the Medical Technology Industry.
Axendia retained full editorial control during the execution, analysis, and compilation of this report.
About Axendia, Inc.
Axendia, Inc. is a leading analyst, and strategic advisory firm focused on the Life-Sciences, and Healthcare markets. We provide trusted advice to Industry Executives on Business, Regulatory, and Technology issues. Axendia professionals offer a unique combination of deep hands-on industry experience coupled with strategic vision. Axendia serves the complete ecosystem including Life-Science, and Healthcare Organizations, Technology & Service Providers, and the Investment community.
Our clients range from startups to Fortune 100. We contribute to our client’s success by providing long-range visibility, and helping them navigate the increasingly complex landscape in the Life-Sciences, and Healthcare markets. For more information, visit http://www.axendia.com or contact us at info(at)axendia(dot)com.
For more information, visit http://www.axendia.com or contact us at info(at)axendia(dot)com, read Axendia’s blog: Life-Science Panorama at http://LSP.axendia.com or follow us on twitter.com/axendia or facebook.com/axendia.